David Nierengarten: Well-Funded VC’s Are Betting Heavily on Biotechs
For more on David Nierengarten’s comments: These 28 biotech startups have attracted the most VC cash, making them prime candidates for an acquisition or IPO
Michael Pachter: I’m Not Sure Any of the Media Stocks Will Hold up in a Recession
For more on Michael Pachter’s comments: Media stocks hammered as a markets plunge
Michael Pachter: Sony Pretty Much Announced All the Games for This Generation
For more on Michael Pachter’s comments: PS5 release date ‘revealed’ by leaked memo – and it could land BEFORE the Xbox 2
Daniel Ives: The iPhone Demand Cycle Looks Stable Heading into Fiscal 2020
For more on Daniel Ives’ comments: Top analyst upgrades and downgrades
Steve Massocca: I Certainly Understand the Rally in Bonds
For more on Steve Massocca’s comments: What is an ‘inverted yield curve’? And why is it being blamed for the Dow’s 800+ point loss?
Daniel Ives: China E-Commerce Players Have Come Under Major Pressure
For more on Daniel Ives’ comments: Alibaba shares pop after earnings beat thanks to e-commerce, cloud as analysts see a big rally ahead